4D Molecular Therapeutics (FDMT) Projected to Post Earnings on Thursday
4D Molecular Therapeutics (NASDAQ:FDMT – Get Free Report) will likely be announcing its Q1 2025 earnings results before the market opens on Thursday, May 8th. Analysts expect 4D Molecular Therapeutics to post earnings of ($0.84) per share and revenue of $0.53 million for the quarter. 4D Molecular Therapeutics (NASDAQ:FDMT – Get Free Report) last posted […]
